All sites C00-96,D32-33,D42-43,D45-47,D76 1523 92.4 2.4 2.4 0.8 2.0
Mouth, pharynx C00-14 34 95.9 0.6 1.2 2.4 -
  Lip C00 3 100.0 - - - -
  Tongue C02 7 100.0 - - - -
  Mouth, other C03-06 7 94.3 - - 5.7 -
  Salivary glands C07-08 4 100.0 - - - -
  Pharynx C01,C09-14 13 92.4 1.5 3.0 3.0 -
Digestive organs C15-26 294 88.8 1.7 4.5 1.6 3.4
  Oesophagus C15 15 85.7 2.6 2.6 1.3 7.8
  Stomach C16 33 95.2 2.4 1.2 0.6 0.6
  Small intestine C17 6 100.0 - - - -
  Colon C18 83 96.9 - 1.0 0.7 1.4
  Rectum, rectosigmoid C19-20 63 95.2 - 1.9 1.0 1.9
  Anus C21 3 100.0 - - - -
  Liver C22 27 82.1 1.5 7.5 3.0 6.0
  Gallbladder, bile ducts C23-24 11 76.4 7.3 7.3 1.8 7.3
  Pancreas C25 48 69.9 5.0 14.2 3.8 7.1
  Other digestive organs C26 5 69.2 3.8 15.4 3.8 7.7
Respiratory organs C30-39 148 75.6 10.7 7.6 1.9 4.2
  Nose, sinuses C30-31 2 100.0 - - - -
  Larynx, epiglottis C32 7 97.0 - - - 3.0
  Lung, trachea C33-34 137 74.1 11.5 8.2 2.0 4.2
  Mediastinum, pleura C38 1 100.0 - - - -
Bone C40-41 2 100.0 - - - -
Melanoma of the skin C43 69 99.7 0.3 - - -
Skin, non-melanoma C44 79 99.5 0.3 - - 0.3
Mesothelioma C45 5 96.0 - - - 4.0
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 8 97.5 - - - 2.5
Breast C50 3 100.0 - - - -
Male genital organs C60-63 533 99.8 - - 0.0 0.2
  Prostate C61 516 99.8 - - 0.0 0.2
  Testis C62 13 100.0 - - - -
  Other male genital C60,C63 4 100.0 - - - -
Urinary organs C64-68 136 94.6 0.7 2.8 1.2 0.7
  Kidney C64 48 91.3 0.4 4.5 2.1 1.7
  Bladder and urinary tract2 C65-68 88 96.4 0.9 1.8 0.7 0.2
Eye C69 1 85.7 - - - 14.3
Brain, central nervous system C70-72,D32-33,D42-43 34 87.1 - 8.8 0.6 3.5
Thyroid gland C73 12 96.8 3.2 - - -
Other endocrine glands C74-75 2 83.3 - - - 16.7
Illdefined or unknown C76,C80 33 69.3 9.6 12.0 3.0 6.0
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 128 84.1 8.0 0.6 0.6 6.7
  Hodgkin lymphoma C81 10 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 58 99.0 0.7 - - 0.3
  Malignant immunoproliferative diseases C88 2 58.3 25.0 - 8.3 8.3
  Myeloma and other plasma cell tumors C90 14 62.5 11.1 5.6 2.8 18.1
  Leukaemia C91-95 33 74.7 17.5 - 0.6 7.2
  Myelodysplastic syndromes D46 3 12.5 25.0 - - 62.5
  Myeloproliferaitive neoplasms D45,D47 6 65.6 15.6 - - 18.8
Not included above
  Basal cell carcinoma of the skin 414 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.